GIORGIONI, Gianfabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.034
EU - Europa 5.170
AS - Asia 4.416
SA - Sud America 508
Continente sconosciuto - Info sul continente non disponibili 278
AF - Africa 202
OC - Oceania 31
Totale 23.639
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.549
CN - Cina 1.723
SG - Singapore 1.310
RU - Federazione Russa 1.247
IT - Italia 1.157
DE - Germania 664
BR - Brasile 417
VN - Vietnam 377
CA - Canada 358
GB - Regno Unito 352
HK - Hong Kong 342
SE - Svezia 302
UA - Ucraina 296
PL - Polonia 269
FR - Francia 266
FI - Finlandia 237
ZA - Sudafrica 140
TR - Turchia 121
KR - Corea 118
IE - Irlanda 87
BD - Bangladesh 83
IN - India 72
NL - Olanda 62
JP - Giappone 56
CZ - Repubblica Ceca 53
MX - Messico 48
BE - Belgio 44
IL - Israele 43
ES - Italia 37
AU - Australia 28
AR - Argentina 27
IQ - Iraq 23
PK - Pakistan 21
UZ - Uzbekistan 17
CR - Costa Rica 15
EG - Egitto 15
EC - Ecuador 14
HR - Croazia 14
IR - Iran 14
PE - Perù 14
AT - Austria 13
EU - Europa 13
SC - Seychelles 12
LT - Lituania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
CO - Colombia 10
GT - Guatemala 10
ID - Indonesia 10
MA - Marocco 10
SA - Arabia Saudita 10
MY - Malesia 9
AZ - Azerbaigian 8
UY - Uruguay 8
GP - Guadalupe 7
HN - Honduras 7
KE - Kenya 7
PT - Portogallo 7
SV - El Salvador 7
VE - Venezuela 7
KG - Kirghizistan 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
CW - ???statistics.table.value.countryCode.CW??? 5
DZ - Algeria 5
EE - Estonia 5
GR - Grecia 5
JM - Giamaica 5
JO - Giordania 5
NP - Nepal 5
PR - Porto Rico 5
RO - Romania 5
TN - Tunisia 5
BB - Barbados 4
BY - Bielorussia 4
CL - Cile 4
NI - Nicaragua 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HU - Ungheria 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
CY - Cipro 2
DK - Danimarca 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
Totale 23.358
Salva come PNG Salva come JPEG
Città #
Ashburn 1.285
Fairfield 768
Woodbridge 757
Singapore 708
Jacksonville 706
San Jose 686
Chandler 534
Dallas 501
Houston 469
Council Bluffs 462
Ann Arbor 446
Wilmington 376
Boardman 334
Hong Kong 334
Seattle 330
Los Angeles 296
Cambridge 287
Beijing 275
New York 247
Nanjing 234
Camerino 202
Toronto 189
Warsaw 170
Princeton 143
Johannesburg 127
Ho Chi Minh City 123
San Mateo 121
Helsinki 119
Santa Clara 116
Seoul 113
The Dalles 108
Tongling 108
Dearborn 106
Lawrence 100
Munich 95
Lauterbourg 92
Kraków 91
Istanbul 89
Orem 89
Columbus 88
Buffalo 85
Dublin 84
Chicago 83
Nanchang 82
Ogden 82
Moscow 80
Phoenix 76
Hanoi 75
London 72
Shenyang 69
Milan 66
Lachine 63
Denver 61
Shanghai 59
Düsseldorf 58
Kunming 56
San Francisco 54
Redwood City 51
Tokyo 50
North Bergen 49
Brooklyn 46
Frankfurt am Main 46
Rome 44
Tianjin 43
Hebei 42
Atlanta 40
Brussels 40
Brno 38
Montreal 35
São Paulo 35
Washington 35
Guangzhou 33
Jiaxing 30
San Diego 30
Philadelphia 28
Trieste 28
Wuhan 28
Changsha 27
Turku 27
Boston 26
Stockholm 26
Augusta 25
Bremen 25
Jinan 25
St Louis 25
Chennai 24
Hangzhou 23
Poplar 23
Ascoli Piceno 22
Centro 22
Da Nang 22
Leawood 21
Ningbo 20
Venezia 19
Zhengzhou 19
Hefei 18
Newark 17
Redondo Beach 17
Venice 17
Auburn Hills 16
Totale 14.906
Salva come PNG Salva come JPEG
Nome #
Quaternary ammonium surfactants derived from leucine and methionine: Novel challenging surface active molecules with antimicrobial activity 974
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 653
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 345
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 344
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 340
5HT2B receptor antagonists: a probe for spotting the pharmacophore 339
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 314
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 301
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 284
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 279
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 273
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 271
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 261
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 259
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 257
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 251
3-[2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl]-5,6,7,8-tetrahydro-4(3H)quinazolinones: serotonin 5-HT2A receptor antagonists endowed with potent, central action 248
Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process 242
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 239
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 238
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 237
Evaluation of methoxy polyethylene glycol-polylactide diblock copolymers as additive in hypromellose film coating 237
Evaluation of polymer mucoadhesiveness by the use of acoustic spectroscopy 236
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 235
Synthesis and pharmacological evaluation of 4-phenoxy-1,2,3,4-tetrahydroisoquinolines and 4,5,6,6a-tetrahydrochromeno [2,3,4-de]isoquinolines 234
Synthesis and Evaluation of 2-(5-Methoxythiophen-3- yl)ethylamines as Potential Dopamine Agonists 234
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 232
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 232
Monitoring the aggregation behaviour of self-assembling polymers through high-resolution ultrasonic spectroscopy, 231
Dimeric L-Dopa Derivatives as Potential Prodrugs 231
Synthesis and Preliminary Pharmacological Evaluation of 5-Hydroxy- and 5,6-Dihydroxy-1,2,3,7,12,12a-hexahydrobenzo [5,6]cyclohepta[1,2,3-ij]isoquinoline Derivatives as Dopamine Receptor Ligands 229
Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands 229
New 2- pyridylethylamines with dopaminergic activity: synthesis and radioligand binding evaluation 229
4-(3-Piridil)-1,2,3,4-tetraidroisochinoline potenziali ligandi dei recettori della dopamina 227
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 226
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 225
Novel Imidazoline Compounds as Partial or Full Agonists of D2-Like Dopamine Receptors Inspired by I2-Imidazoline Binding Sites Ligand 2-BFI 223
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 222
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 221
Thermosensitive self-assembling block copolymers as drug delivery systems 221
Synthesis and Pharmacological Characterization of 2-(4-Chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl Derivatives as Dopamine Receptor Ligands 220
Dopamine D-5 receptors: A challenge to medicinal chemists 220
Novel Dopamine Receptor Ligands Bearing Imidazoline Nucleus. 216
Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-Dopa 216
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 216
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 215
4WD to Travel Inside the 5-HT1A Receptor World 213
New Systems for the Specific Delivery and Sustained Release of Dopamine to the Brain 212
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 211
New L-dopa codrugs as potential antiparkinson agents 209
trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D-1 receptor full agonist 206
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 206
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 205
Evaluation of 2,3,4,8,13a hexahydro-1H-benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 204
Glycosyl and polyalcoholic prodrugs of lonidamine. 204
Synthesis, resolution and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptor ligands 203
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 202
Chemical–physical properties and cytotoxicity of N-decanoyl amino acid-based surfactants: Effect of polar heads 201
Correlation among chemical structure, surface properties and cytotoxicity of N-acyl alanine and serine surfactants 200
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 200
Quaternary Ammonium Leucine-Based Surfactants: The Effect of a Benzyl Group on Physicochemical Properties and Antimicrobial Activity 198
Activity of N-(2-Phenylethyl)-N-n-Propyl-2-(3-Hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 196
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 196
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 193
Design, synthesis and preliminary pharmacological evaluation of new imidazolinonesas L-DOPA prodrugs 190
DISCOVERY OF NEW POTENTIAL gamma-SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 189
Synthesis and Biological Evaluation of GABA Derivatives Able to Cross the Blood -Brain Barrier in Rats 189
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 189
A Comparative Behavioural Analysis in Rats of the D2 Agonist RU 24213 and Two New Structurally Similar Compounds 187
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 186
4-Aryloxy-1,2,3,4-tetrahydroisoquinolines as new potential antipsychotic drugs 181
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinoles as dopamine receptor ligands 180
Receptors in aging diseases: Dopamine receptors 179
Polyhydroxylic Prodrugs of Lonidamine 176
A de novo design probe of a dopamine receptor ligand based on a theoretical approach 174
Imidazolidinoni profarmaci della L-DOPA 174
Synthesis and SAR of group 11 N-heterocyclic carbene complexes 173
Synthesis and Evaluation of N-n-Propyl-N-(2-phenylethyl)-2-(3-fluoro-4- hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 173
Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives 171
Toxicological profiles and surface properties at physiological pH of N-decanoyl amino acids 171
Preparation and Pharmacological Characterization of trans-2-Amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like Dopamine Receptor Agonists 167
Structure-Activity Relationships of N-n-Propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 164
Novel antitumor Cu(I) and Cu(II) complexes based on bioconjugate ligands rationally designed to act through synergistic mechanisms 158
Synthesis and Dopamine Receptor Binding of 4-(2-Aminoethyl)-1H-pyrazole and Its N,N- Dialkyl Derivatives 152
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma 152
L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents 151
Copper complexes with adamantane ring-conjugated ligands as promising agents for the treatment of glioblastoma 148
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma 147
Receptors in aging disease 145
Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or cognitive and memory performances impaired by scopolamine treatment orlesions of the nucleus basalis of Meynert 143
Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma 142
Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma 140
ANTIDEPRESSANT-LIKE ACTIVITY OF NOVEL IMIDAZOLINE LIGANDS DIRECTED TO THE SEROTONIN 5-HT1A RECEPTOR 138
New anticancer copper complexes containing ligands conjugated with biologically active molecules 137
Copper Complexes with Adamantane Ring- Conjugated Ligands as Promising Agents for the Treatment of Glioblastoma 136
Investigating the role of the central melanocortin system in stress and stress-related disorders 136
Effect on binge eating episode in female rats of a potent 1 antagonist analogue of spipethiane 134
IBUPROFEN AND LIPOIC ACID DIAMIDE AS CO-DRUGS WITH NEUROPROTECTIVE ACTIVITY: PHARMACOLOGICAL PROPERTIES AND EFFECTS IN Βeta-AMYLOID (1-40) INFUSED ALZHEIMER’S DISEASE RAT MODEL 129
Trends in drug Research 129
Medicinal chemistry and pharmacology of purinergic receptors 129
Totale 22.024
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022638 0 0 0 0 84 57 35 73 86 117 56 130
2022/20231.484 180 49 75 194 163 201 17 90 264 79 122 50
2023/20241.084 127 61 100 34 39 93 57 36 118 35 24 360
2024/20253.739 167 88 318 165 85 203 453 901 289 237 243 590
2025/20266.549 343 343 693 837 560 423 897 419 333 365 1.110 226
2026/20272.141 324 175 491 897 254 0 0 0 0 0 0 0
Totale 23.639